Overview

A HR20031 FE Study on Healthy Subjects

Status:
Not yet recruiting

Trial end date:
2023-03-15

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the effect of food on the single-dose PK of SHR3824, SP2086 and metformin in the HR20031 FDC tablets in healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Shandong Suncadia Medicine Co., Ltd.